Fobi AI Announces Completion of Second Tranche Of Non-Brokered Private Placement
globenewswire.com
Want to monitor STOK?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor STOKstoke is developing antisense oligonucleotide medicines that target rna splicing to increase gene expression for the treatment of severe genetic diseases.